Introduction. Breast cancer (BC) is the most commonly diagnosed cancer and a leading cause of death among women in the UK and worldwide.1 Annually, around 55 000 women are diagnosed with BC and 11 500 ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

A Caltech-led team has developed a safe, effective, and painless breast imaging technique that incorporates machine learning ...

A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...

When she brought up cryoablation to her medical oncologist at the University of Alabama at Birmingham O’Neal Comprehensive ...

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

Layne Horwich lives independently, found the lump herself and surprised doctors with her treatment choice. What older women ...

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to ...

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

AstraZeneca wants to make its oral selective oestrogen receptor degrader (SERD) drug camizestrant a go-to frontline therapy for HR-positive breast cancer, and made its case at ASCO with data from ...